Abstract: A speaking valve for management of a patient's airway comprising a body rotatably and removably attachable to a tracheotomy tube, the body having a first end communicable with the tracheotomy tube and a second end distal from the first end, an offset opening formed in the second end, a ramp disposed within the body, a ball having a diameter disposed within the chamber, the ball being adapted to be guided up and down the ramp and able to partially close the opening in the second end of the body, and the body and hence the chamber therein, at the option and control of the patient, wherein the ball is adapted to move up and down the ramp opening and partially closing the opening in the second end of the body and, as selected, exhalation by the patient proceeds through the patient's upper respiratory system and facilitates speaking by the patient.

Abstract: Described is a composition comprising one or more active ingredients coated, dispersed, or dissolved with a mucoadhesive polymer. Although subject to multiple uses, the composition, in some embodiments, is usable for treating rhinosinusitis.

Abstract: A speaking valve for management of a patient's airway comprising a body rotatably and removably attachable to a tracheotomy tube, the body having a first end communicable with the tracheotomy tube and a second end distal from the first end, an offset opening formed in the second end, a ramp disposed within the body, a ball having a diameter disposed within the chamber, the ball being adapted to be guided up and down the ramp and able to partially close the opening in the second end of the body, and the body and hence the chamber therein, at the option and control of the patient, wherein the ball is adapted to move up and down the ramp opening and partially closing the opening in the second end of the body and, as selected, exhalation by the patient proceeds through the patient's upper respiratory system and facilitates speaking by the patient.

Abstract: A heat moisture exchange device received on a speaking tube mounted on an end of a tracheotomy tube. The heat moisture exchange device has a housing in which the air moves in a turbulent manner and passes through a heat moisture exchange filter.

Abstract: The herein disclosed invention is directed to methods of treating difficult to treat refractory or recalcitrant rhinosinusitis involving the steps of (1) topical application of antimicrobials/antibiotics and corticosteroids, (2) endoscopic debridement and cleansing to remove debris and biofilm, (3) endoscopic instillation of antimicrobials/antibiotics plus corticosteroids to the sinuses, and (4) hydrotherapy to disrupt/inhibit bacterial/fungal biofilm attachment to the sinus mucosa. Also disclosed is a kit of components for carrying out the treatment of this invention.

Abstract: A heat moisture exchange device received on a speaking tube mounted on an end of a tracheotomy tube. The heat moisture exchange device has a housing in which the air moves in a turbulent manner and passes through a heat moisture exchange filter.

Abstract: A speaking tube for a patient's airway management having a body with a chamber formed therein connected to a tracheotomy tube. A plurality of ramps are disposed within the chamber retaining a ball therein. The body is rotatable through 180° to adjust the positioning of the ball when the patient inhales and exhales, thereby facilitating speech by the patient. An adapter for heat moisture exchange is attachable to the body.

Abstract: Disclosed is a method of growing cells on biodegradable microcarrier particles and more specifically growing chondrocytes for an extended period of time until they aggregate. These aggregated cells can be injected directly or shaped for implantation into the body. In another embodiment of this invention, the cell microcarrier aggregates are grown in a mold that is shaped to conform to the geometry of the desired body part to be replaced. An apparatus for shaping the aggregated cells is disclosed. The aggregated cells can be supplied in a kit.

Abstract: This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component.

Abstract: The invention is directed to the culture of cells, and particularly chondrocytes for purpose of tissue replacement. The cells are cultured on polymer constructs. Integren expression is used as a measure of chondrocyte viability. Chondrocytes are obtained from the knee, nose and ankle cartilage. Mechanical strain is used to propagate chondrocytes, chitosan and arabinogalactan-chitosan are used as scaffolds. Progenitor, pluripotential, stem and mesenchymal cells are operative in this invention.

Abstract: This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component.

Abstract: The invention is directed to the culture of cells, and particularly chondrocytes for purpose of tissue replacement. The cells are cultured on polymer constructs. Integren expression is used as a measure of chondrocyte viability. Chondrocytes are obtained from the knee, nose and ankle cartilage. Mechanical strain is used to propagate chondrocytes, chitosan and arabinogalactanchitosan are used as scaffolds. Progenitor, pluripotential, stem and mesenchymal cells are operative in this invention.

Abstract: A speaking valve for a tracheostomy tube which is disposed in the first end of the tube protruding from the throat of the patient. The valve has guiding ribs and a retainer to retain a ball within the end of the tube. The flow of air around the ball is unrestricted to reduce the force required to move the ball when the patient inhales and exhales. A spherical chamber is formed in which the ball is disposed. The tracheostomy tube with the valve in the first end presents a low profile.

Abstract: A speaking valve for a tracheostomy tube which is disposed in the first end of the tube protruding from the throat of the patient. The valve has guiding ribs and a retainer to retain a ball within the end of the tube. The flow of air around the ball is unrestricted to reduce the force required to move the ball when the patient inhales and exhales. A spherical chamber is formed in which the ball is disposed. The tracheostomy tube with the valve in the first end presents a low profile.

Abstract: A tracheostomy tube has a cannula and a neckpiece with bands. The distal ends of the bands are rapidly and releasably connected to one another. At least one of the bands is adjustable in length. The bands and the neck piece may be formed integrally into a unitary member. The bands and neck piece may be formed from a viscoelastic polymer. A method of use is disclosed.

Abstract: Cells grown on a microcarrier are separated from the microcarrier by enzymatically digesting the microcarrier. More specifically, chondrocytes may be grown on dextran microcarrier beadlets and then the beadlets digested using dextranase to separate the chondrocytes from the carrier. Cells can also be grown on chitosan microcarriers to be used for implantation. In addition, cells can be grown on polysaccharide polymers to be used as implant devices. Various polymers serve as scaffolds for cells to be used for implantation. The polymers can be used for cell culture as well as for preparing scaffolds useful for tissue replacement such as cartilage tissue.

Abstract: Cells grown on a microcarrier are separated from the microcarrier by enzymatically digesting the microcarrier. More specifically, chondrocytes may be grown on dextran microcarrier beadlets and then the beadlets digested using dextranase to separate the chondrocytes from the carrier. Cells can also be grown on chitosan microcarriers to be used for implantation. In addition, cells can be grown on polysaccharide polymers to be used as implant devices. Various polymers serve as scaffolds for cells to be used for implantation. The polymers can be used for cell culture as well as for preparing scaffolds useful for tissue replacement such as cartilage tissue.

Abstract: Cells grown on a microcarrier are separated from the microcarrier by enzymatically digesting the microcarrier. More specifically, chondrocytes may be grown on dextran microcarrier beadlets and then the beadlets digested using dextranase to separate the chondrocytes from the carrier. Cells can also be grown on chitosan microcarriers to be used for implantation. In addition, cells can be grown on polysaccharide polymers to be used as implant devices. Various polymers serve as scaffolds for cells to be used for implantation. The polymers can be used for cell culture as well as for preparing scaffolds useful for tissue replacement such as cartilage tissue.

Abstract: This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component.

Abstract: A heat moisture exchange device received on a speaking tube mounted on an end of a tracheotomy tube. The heat moisture exchange device has a housing in which the air moves in a turbulent manner and passes through a heat moisture exchange filter.